Cardioprotective mechanisms of SGLT2 inhibitors: What do cardiologists need to know?

10' education - Sep. 24, 2019 - Prof. Nikolaus Marx, MD - Aachen, Germany

Video navigation menu

Clinical observations with SGLT2 inhibitor treatment 0:44
Potential hemodynamic effects of SGLT2 inhibitors 2:09
Potential metabolic effects of SGLT2 inhibitors 4:15
Early and long-term effects of SGLT2 inhibitors explained 7:42

Educational information

This lecture by prof. Nikolaus Marx was part of an accredited symposium "Expanding opportunities for SGLT2i in clinical cardiology" held during ESC 2019 in Paris, France.

Faculty

Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim/Lilly.

View slides of this presentation Go to the meeting report of this symposium

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.